Randox Life Sciences has developed an extensive range of drug-targeted antibodies for research and development applications. The company’s high-quality, cost-effective antibodies and conjugates are specific to a range of drugs of abuse targets including antidepressants, barbiturates, benzodiazepines, hallucinogens, opiates, sedatives, stimulants, and therapeutic drugs.

Randox Life Sciences are continually developing antibodies to new drugs of abuse targets. The company has recently released a range of drug-targeted antibodies including anti-haloperidol, anti-methicathinone, anti-norfentanyl, and therapeutic antibody anti-theophylline suitable for use in the development of in-house detection methods such as ELISA. The antibodies have corresponding HRP conjugates (tracers) available free for a limited time only with each order.